10 Biggest Stock Price Target Changes for April 22
Canaccord Genuity lowered the stock price target for Canadian Tire (OTCPK:CDNAF) from $160 to $108. The brokerage gave the stock a Hold rating. CDNAF stock closed at $66.83 on April 22. Jefferies Financial Group raised ... [Read]
CARA Stock Continues to Rise: Reasons to Watch This BioTech Stock
A biotechnology company firmly on the radar is Cara Therapeutics (NASDAQ:CARA). The US-based drug developer was recently successful in its trialing of lead candidate Korsuva. At the end of May, CARA stock popped as the ... [Read]
CARA Stock Skyrockets 20% After Positive Results On KORSUVA
CARA stock is on fire as Cara Therapeutics Inc (NASDAQ:CARA) reported positive topline results from a Phase 3 clinical trial, KALM-1, evaluating KORSUVA. Cara’s KORSUVA Successful As far as therapeutics companies are concerned, the completion ... [Read]
Cara Therapeutics Enters into Agreement With Vifor Fresenius
Connecticut-based biotechnology company Cara Therapeutics (NASDAQ:CARA) has announced that it has entered into an agreement with Vifor Fresenius Medical Care Renal Pharma Ltd. on Wednesday. Vifor Fresenius, a joint company from Vifor Pharma Group (SIX:VIFN) and ... [Read]